Abstract:Tumor suppressor p53 is the most frequently mutated gene in human tumors. Meanwhile, under stress conditions, p53 also acts as a transcription factor, regulating the expression of a series of target genes to maintain the integrity of genome. The target genes of p53 can be classified into genes regulating cell cycle arrest, genes involved in apoptosis, and genes inhibiting angiogenesis. p53 protein contains a transactivation domain, a sequence-specific DNA binding domain, a tetramerization domain, a non-specific DNA binding domain that recognizes damaged DNA, and a later identified proline-rich domain. Under stress, p53 proteins accumulate and are activated through two mechanisms. One, involving ataxia telangiectasia-mutated protein (ATM), is that the interaction between p53 and its down-regulation factor murine double minute 2 (MDM2) decreases, leading to p53 phosphorylation on Ser15, as determined by the post-translational mechanism; the other holds that p53 increases and is activated through the binding of ribosomal protein L26 (RPL26) or nucleolin to p53 mRNA 5( untranslated region (UTR), regulating p53 translation. Under hypoxia, p53 decreases transactivation and increases transrepression. The mutations outside the DNA binding domain of p53 also contribute to tumor progress, so further studies on p53 should also be focused on this direction. The subterranean blind mole rat Spalax in Israel is a good model for hypoxia-adaptation. The p53 of Spalax mutated in residue 172 and residue 207 from arginine to lysine, conferring it the ability to survive hypoxic conditions. This model indicates that p53 acts as a master gene of diversity formation during evolution.

SENP3 Postpones Cellular Senescence of P53-mediated Pathway under Mild Oxidative Stress

SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative Stress

Role of p53 in the Regulation of Cellular Senescence

P53, Oxidative Stress, and Aging

Does Nrf2 Contribute to P53-Mediated Control of Cell Survival and Death?

Tumor Suppression by P53: Making Cells Senescent.

Tip30 Induces Apoptosis under Oxidative Stress Through Stabilization of P53 Messenger Rna in Human Hepatocellular Carcinoma

Hsp90β Interacts with MDM2 to Suppress P53‐dependent Senescence During Skeletal Muscle Regeneration

Senescence regulation by the p53 protein family.

Cellular adaptation to hypoxia and p53 transcription regulation

The Responses of SENP3 to Different Extents of Oxidative Stress

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

Persistent P21 Expression after Nutlin-3a Removal is Associated with Senescence-Like Arrest in 4n Cells

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence

Nqo1 Stabilizes P53 In Response To Oncogene-Induced Senescence

Influence of oxidative stress on p53 post-translational modifications

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

Chemokine Receptor CXCR2 is Transactivated by P53 and Induces P38‐mediated Cellular Senescence in Response to DNA Damage

Functional Role of P53 in the Regulation of Chemical-Induced Oxidative Stress

P53 Suppresses SENP3 Phosphorylation to Mediate G2 Checkpoint.

PTEN Nuclear Localization is Regulated by Oxidative Stress and Mediates P53-Dependent Tumor Suppression